Nanoparticle-based drug delivery systems: an inspiring therapeutic strategy for neurodegenerative diseases
L Duan, X Li, R Ji, Z Hao, M Kong, X Wen, F Guan… - Polymers, 2023 - mdpi.com
Neurodegenerative diseases are common, incurable neurological disorders with high
prevalence, and lead to memory, movement, language, and intelligence impairments …
prevalence, and lead to memory, movement, language, and intelligence impairments …
Peptides as pharmacological carriers to the brain: promises, shortcomings and challenges
S Parrasia, I Szabò, M Zoratti… - Molecular …, 2022 - ACS Publications
Central nervous system (CNS) diseases are among the most difficult to treat, mainly
because the vast majority of the drugs fail to cross the blood-brain barrier (BBB) or to reach …
because the vast majority of the drugs fail to cross the blood-brain barrier (BBB) or to reach …
Altered cholesterol homeostasis in Huntington's disease
Huntington's disease (HD) is an autosomal dominant genetic disorder caused by an
expansion of the CAG repeat in the first exon of Huntingtin's gene. The associated …
expansion of the CAG repeat in the first exon of Huntingtin's gene. The associated …
Biopolymer nanoparticles for nose-to-brain drug delivery: A new promising approach for the treatment of neurological diseases
Diseases affecting the central nervous system (CNS) are among the most disabling and the
most difficult to cure due to the presence of the blood–brain barrier (BBB) which represents …
most difficult to cure due to the presence of the blood–brain barrier (BBB) which represents …
Focusing the pivotal role of nanotechnology in Huntington's disease: an insight into the recent advancements
S Singh, Hema, N Sharma, M Sachdeva, T Behl… - … Science and Pollution …, 2022 - Springer
Neurodegeneration is the loss of neuronal capacity and structure over time which causes
neurodegenerative disorders like Alzheimer, amyotrophic lateral sclerosis, Parkinson, and …
neurodegenerative disorders like Alzheimer, amyotrophic lateral sclerosis, Parkinson, and …
Emerging strategies to fabricate polymeric nanocarriers for enhanced drug delivery across blood-brain barrier: An overview
Blood-brain barrier (BBB) serves as an essential interface between central nervous system
(CNS) and its periphery, allowing selective permeation of ions, gaseous molecules, and …
(CNS) and its periphery, allowing selective permeation of ions, gaseous molecules, and …
Neuronal and astrocytic contributions to Huntington's disease dissected with zinc finger protein transcriptional repressors
Huntington's disease (HD) is caused by expanded CAG repeats in the huntingtin gene (HTT)
resulting in expression of mutant HTT proteins (mHTT) with extended polyglutamine tracts …
resulting in expression of mutant HTT proteins (mHTT) with extended polyglutamine tracts …
The translational potential of cholesterol-based therapies for neurological disease
M Valenza, G Birolini, E Cattaneo - Nature Reviews Neurology, 2023 - nature.com
Cholesterol is an important metabolite and membrane component and is enriched in the
brain owing to its role in neuronal maturation and function. In the adult brain, cholesterol is …
brain owing to its role in neuronal maturation and function. In the adult brain, cholesterol is …
[HTML][HTML] Advances in nanotechnology versus stem cell therapy for the theranostics of Huntington's disease
Huntington's disease (HD) is a neurological disorder characterized by a reduction in
medium-spiny neurons in the brain. Currently, there is no cure for HD and treatment relies …
medium-spiny neurons in the brain. Currently, there is no cure for HD and treatment relies …
Optimization of an injectable hydrogel depot system for the controlled release of retinal-targeted hybrid nanoparticles
A drawback in the development of treatments that can reach the retina is the presence of
barriers in the eye that restrain compounds from reaching the target. Intravitreal injections …
barriers in the eye that restrain compounds from reaching the target. Intravitreal injections …